Dual-Target CAR-NK Cells for Advanced Breast Cancer (HER2+ and TNBC)

NCT07486089 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer (Locally Advanced or Metastatic)
HER2-positive Breast Cancer
Triple-Negative Breast Cancer (TNBC)

Interventions

BIOLOGICAL: Dual-target CAR-NK cells (EB-DT-CAR-NK)
DRUG: Lymphodepleting chemotherapy
OTHER: Supportive care

Sponsor

Beijing Biotech